Department of Internal Medicine, Section of Molecular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
Osteoarthritis Cartilage. 2010 Aug;18(8):1096-103. doi: 10.1016/j.joca.2010.05.013. Epub 2010 May 25.
Mineralization has been observed in osteoarthritic cartilage but the mechanisms are incompletely understood. Vitamin K is an essential cofactor in post-translational modification of proteins where specific Glu residues become modified to Ca(++) binding gamma-carboxyglutamic acid residues (Gla). One such protein, matrix Gla protein (MGP), is a known mineralization inhibitor. This study determined if synthesis of MGP and formation of a fetuin-MGP protein complex was altered in chondrocytes and vesicles from osteoarthritis (OA) cartilage.
Chondrocytes and vesicles were isolated from normal and OA human articular cartilage and lysates prepared. Specific antibodies were used in immunoblotting to detect the mature fully gamma-carboxylated form of MGP (cMGP) and non-gamma-carboxylated MGP (ucMGP) as well as fetuin and MGP-fetuin complexes. gamma-carboxylase activity was measured by (14)CO(2) incorporation into the carboxylase peptide substrate FLEEL. Immunocytochemistry was used to examine fetuin in cartilage sections and uptake of biotin-labeled fetuin by isolated chondrocytes.
Chondrocytes and vesicles from osteoarthritic tissue produced significantly less cMGP compared to those from normal cartilage. This correlated with significantly less vitamin K-dependent gamma-carboxylase enzyme activity in OA chondrocytes. Fetuin was found to be present in articular cartilage and cultured chondrocytes were capable of fetuin uptake. A fetuin-MGP complex was identified in normal chondrocytes and in vesicles shed from these cells but not in OA cells or vesicles.
The absence of cMGP and of the cMGP-fetuin complex in OA cells and OA vesicles may be an important mechanism for increased mineralization of osteoarthritic cartilage.
在骨关节炎软骨中观察到了矿化现象,但机制尚不完全清楚。维生素 K 是蛋白质翻译后修饰的必需辅助因子,其中特定的 Glu 残基被修饰为 Ca(++)结合的γ-羧基谷氨酸残基(Gla)。一种这样的蛋白质,基质 Gla 蛋白(MGP),是一种已知的矿化抑制剂。本研究旨在确定在骨关节炎(OA)软骨的软骨细胞和小泡中,MGP 的合成和胎球蛋白-MGP 蛋白复合物的形成是否发生改变。
从正常和 OA 人关节软骨中分离软骨细胞和小泡,并制备裂解物。使用特异性抗体在免疫印迹中检测成熟的完全γ-羧化形式的 MGP(cMGP)和非γ-羧化的 MGP(ucMGP)以及胎球蛋白和 MGP-胎球蛋白复合物。通过(14)CO(2)掺入羧化酶肽底物 FLEEL 来测量γ-羧化酶活性。免疫细胞化学用于检查软骨切片中的胎球蛋白和分离的软骨细胞对生物素标记的胎球蛋白的摄取。
与正常软骨相比,来自 OA 组织的软骨细胞和小泡产生的 cMGP 明显减少。这与 OA 软骨细胞中维生素 K 依赖性γ-羧化酶活性显著降低相关。发现胎球蛋白存在于关节软骨中,培养的软骨细胞能够摄取胎球蛋白。在正常软骨细胞和从这些细胞释放的小泡中鉴定出了胎球蛋白-MGP 复合物,但在 OA 细胞或小泡中没有鉴定出。
OA 细胞和 OA 小泡中缺乏 cMGP 和 cMGP-胎球蛋白复合物可能是骨关节炎软骨矿化增加的重要机制。